Indication
Wilson's disease
Wilson's disease is a rare, inherited autosomal recessive disorder of copper metabolism caused by pathogenic variants in the ATP7B gene. Read more about Wilson's disease
35 drugs 26 manufacturers
Drugs that treat it
Common Wilson's disease therapies.
WILZIN (zinc acetate)
DEPEN TITRATABS (penicillamine)
CUVRIOR (trientine tetrahydrochloride)
TRIENTINE HCL
PENICILLAMINE
TRIENTINE HCL
PENICILLAMINE
TRIENTINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonWilson's disease is a rare, inherited autosomal recessive disorder of copper metabolism caused by pathogenic variants in the ATP7B gene.
This genetic defect impairs hepatic copper transport into bile and incorporation into ceruloplasmin, resulting in progressive, pathological copper overload.
The accumulation primarily affects the liver, central nervous system, and corneas, typically manifesting in children, adolescents, and young adults.
Clinical hallmarks include chronic hepatitis, cirrhosis, or acute liver failure, often accompanied by movement disorders, tremors, dysarthria, psychiatric disturbances, and characteristic copper deposits in Descemet's membrane of the eye known as Kayser-Fleischer rings.
- medlineplus.gov
Wilson's disease is a rare, inherited autosomal recessive disorder of copper metabolism caused by pathogenic variants in the ATP7B gene The accumulation primarily affects the liver, central nervous system, and corneas, typically manifesting in children, adolescents, and young adults Clinical hallmarks include chronic hepatitis, cirrhosis, or acute liver failure, often accompanied by movement disorders, tremors, dysarthria, psychiatric disturbances, and characteristic copper deposits in Descemet'...
- nih.gov
Wilson's disease is a rare, inherited autosomal recessive disorder of copper metabolism caused by pathogenic variants in the ATP7B gene Clinical hallmarks include chronic hepatitis, cirrhosis, or acute liver failure, often accompanied by movement disorders, tremors, dysarthria, psychiatric disturbances, and characteristic copper deposits in Descemet's membrane of the eye known as Kayser-Fleischer rings
- nih.gov
This genetic defect impairs hepatic copper transport into bile and incorporation into ceruloplasmin, resulting in progressive, pathological copper overload
- nih.gov
This genetic defect impairs hepatic copper transport into bile and incorporation into ceruloplasmin, resulting in progressive, pathological copper overload Clinical hallmarks include chronic hepatitis, cirrhosis, or acute liver failure, often accompanied by movement disorders, tremors, dysarthria, psychiatric disturbances, and characteristic copper deposits in Descemet's membrane of the eye known as Kayser-Fleischer rings
- nih.gov
The accumulation primarily affects the liver, central nervous system, and corneas, typically manifesting in children, adolescents, and young adults
Personalize your experience
Follow Wilson's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.